By designating only one reference outlined drug as the normal to which all generic versions should be shown to generally be bioequivalent, FDA hopes in order to avoid achievable significant variations among generic drugs and their brand name counterpart. Quoted prices are for income-having to pay prospects and so are not valid with insurance des